References:
1. Yach D, Hawkes C, Gould CL, Hofman KJ. The global burden of chronic
diseases: overcoming impediments to prevention and control. JAMA
2004;291(21):2616-22.
2. Liccardi G, Salzillo A, Calzetta L, Cazzola M, Matera MG, Rogliani P.
Can bronchial asthma with an highly prevalent airway (and systemic)
vagal tone be considered an independent asthma phenotype? Possible role
of anticholinergics. Respir Med 2016;117:150-3.
3. Szekely JI, Pataki A. Recent findings on the pathogenesis of
bronchial asthma. Part II. The role of hormonal predisposition,
environmental influences and conditioning leading to bronchial asthma.
Acta Physiol Hung 2009;96(3):289-305.
4. Lutz W, Sulkowski WJ. Vagus nerve participates in regulation of the
airways: inflammatory response and hyperreactivity induced by
occupational asthmogens. Int J Occup Med Environ Health
2004;17(4):417-31.
5. Liu R, Song J, Li H, Wu Z, Chen H, Wu W, et al. Treatment of canine
asthma by high selective vagotomy. J Thorac Cardiovasc Surg
2014;148(2):683-9.
6. Buhl R, Hamelmann E. Future perspectives of anticholinergics for the
treatment of asthma in adults and children. Ther Clin Risk Manag
2019;15:473-485.
7. Gudovskii LM, Karashurov SE, Karashurov ES, Volkov AA, Parshin VD.
[Surgical treatment of bronchial asthma]. Khirurgiia (Mosk)
2002(7):14-8.
8. Chen X, Zeng M, He D, Yan X, Chen H, Chen Y, et al. Asthmatic
Augmentation of Airway Vagal Activity Involves Decreased Central
Expression and Activity of CD73 in Rats. ACS Chem Neurosci
2019;10(6):2809-2822.
9. Thomson NC. Clinical Studies of Statins in Asthma and COPD. Curr Mol
Pharmacol 2017;10(1):60-71.
10. Zeki AA, Elbadawi-Sidhu M. Innovations in asthma therapy: is there a
role for inhaled statins? Expert Rev Respir Med 2018;12(6):461-473.
11. Al-Sawalha NA, Knoll BJ. Statins in Asthma: A Closer Look into the
Pharmacological Mechanism of Action. Pharmacology 2016;98(5-6):279-283.
12. Bhattacharjee D, Chogtu B, Magazine R. Statins in Asthma: Potential
Beneficial Effects and Limitations. Pulm Med 2015;2015:835204.
13. So JY, Dhungana S, Beros JJ, Criner GJ. Statins in the treatment of
COPD and asthma-where do we stand? Curr Opin Pharmacol 2018;40:26-33.
14.
Zhang
XJ, Qin JJ, Cheng X, Shen L, Zhao YC, Yuan Y, et al. In-Hospital Use of
Statins Is Associated with a Reduced Risk of Mortality among Individuals
with COVID-19. Cell Metab 2020.
15. Obata T, Nakashima M. Fluvastatin, an HMG-CoA reductase inhibitor,
facilitate adenosine production in the rat hearts via activation of
ecto-5’-nucleotidase. Microvasc Res 2016;107:1-5.
16. Ledoux S, Laouari D, Essig M, Runembert I, Trugnan G, Michel JB, et
al. Lovastatin enhances ecto-5’-nucleotidase activity and cell surface
expression in endothelial cells: implication of rho-family GTPases. Circ
Res 2002;90(4):420-7.
17. Meijer P, Oyen WJ, Dekker D, van den Broek PH, Wouters CW, Boerman
OC, et al. Rosuvastatin increases extracellular adenosine formation in
humans in vivo: a new perspective on cardiovascular protection.
Arterioscler Thromb Vasc Biol 2009;29(6):963-8.
18. Zukowska P, Kutryb-Zajac B, Toczek M, Smolenski RT, Slominska EM.
The role of ecto-5’-nucleotidase in endothelial dysfunction and vascular
pathologies. Pharmacol Rep 2015;67(4):675-81.
19. Meijer P, Wouters CW, van den Broek PH, de Rooij M, Scheffer GJ,
Smits P, et al. Upregulation of ecto-5’-nucleotidase by rosuvastatin
increases the vasodilator response to ischemia. Hypertension
2010;56(4):722-7.
20. Osman L, Amrani M, Ilsley C, Yacoub MH, Smolenski RT. Atorvastatin
accelerates extracellular nucleotide degradation in human endothelial
cells. Mol Cell Biochem 2008;308(1-2):209-17.
21. Osman L, Amrani M, Isley C, Yacoub MH, Smolenski RT. Stimulatory
effects of atorvastatin on extracellular nucleotide degradation in human
endothelial cells. Nucleosides Nucleotides Nucleic Acids
2006;25(9-11):1125-8.
22. He D, Chen H, Zeng M, Xia C, Wang J, Shen L, et al. Asthmatic Airway
Vagal Hypertonia Involves Chloride Dyshomeostasis of Preganglionic
Neurons in Rats. Front Neurosci 2020;14:31.
23. ”Global strategy for asthma management and prevention: GINA
executive summary.” E.D. Bateman, S.S. Hurd, P.J. Barnes, J. Bousquet,
J.M. Drazen, J.M. FitzGerald, P. Gibson, K. Ohta, P. O’Byrne, S.E.
Pedersen, E. Pizzichini, S.D. Sullivan, S.E. Wenzel and H.J. Zar. Eur
Respir J 2008; 31: 143-178. Eur Respir J 2018;51(2).
24. Wu KL, Hung CY, Chan JY, Wu CW. An increase in
adenosine-5’-triphosphate (ATP) content in rostral ventrolateral medulla
is engaged in the high fructose diet-induced hypertension. J Biomed Sci
2014;21:8.